Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin (ATG) in Steroid-Refractory Acute Graft Versus Host Disease
NCT00409695Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2006
- Primary completion
- Aug 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in graft-versus-host disease (GVHD), sponsored by University of Texas MD Anderson Cancer Center. Started Dec 2006; status: terminated.
02
Drugs
antithymocyte globulin
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT00409695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00409695.